منابع مشابه
Pharmacological Treatment of Uterine Fibroids
Uterine fibroids (UF) are common, benign gynecologic tumors, affecting one in three to four women, with estimates of up to 80%, depending on the population studied. Their etiology is not well established, but it is under the influence of several risk factors, such as early menarche, nulliparity and family history. More than 50% of affected women are asymptomatic, but the lesions may be related ...
متن کاملUterine Fibroids: Diagnosis and Treatment.
Uterine fibroids are common benign neoplasms, with a higher prevalence in older women and in those of African descent. Many are discovered incidentally on clinical examination or imaging in asymptomatic women. Fibroids can cause abnormal uterine bleeding, pelvic pressure, bowel dysfunction, urinary frequency and urgency, urinary retention, low back pain, constipation, and dyspareunia. Ultrasono...
متن کاملTreatment For Symptomatic Uterine Fibroids
Symptomatic fibroids affect one in every three women over the age of 35, and are responsible for approximately 30% of all hysterectomies. The precise etiology of fibroids is unknown, but studies suggest that estrogen stimulation is an important factor. Fibroids tend to grow after puberty or during pregnancy, and usually decrease in volume in the post-menopausal period. Classification of Fibroid...
متن کاملCurrent medical treatment of uterine fibroids
Uterine fibroids (leiomyomas or myomas), benign monoclonal tumors, are the most common benign tumors in women. Heavy or prolonged menstrual bleeding, abnormal uterine bleeding, resultant anemia, pelvic pain, infertility, and/or recurrent pregnancy loss are generally associated with uterine fibroids. Although curative treatment of this tumor relies on surgical therapies, medical treatments are c...
متن کاملThe Medical Treatment of Uterine Fibroids
8 Other Available Therapies ................................................. 23 8.1 Danazol .................................................................................. 23 8.2 Cabergoline ............................................................................ 24 8.3 Gestrinone .............................................................................. 24 8.4 Oral Contraceptives ....
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Lancet
سال: 1924
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(01)63505-0